Coagulation abnormalities in patients with cyanotic congenital heart disease

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 16, Issue 6, 2002, Pages 752-765

  Tempe, Deepak K ^a   Virmani, Sanjula ^a  

^a G B PANT HOSPITAL   (India)

Author keywords

Bleeding; Cardiac surgery; Coagulation; Cyanotic heart disease

Indexed keywords

AMINOCAPROIC ACID; APROTININ; BLOOD CLOTTING FACTOR; DESMOPRESSIN; TRANEXAMIC ACID;

BLEEDING; BLOOD AUTOTRANSFUSION; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CYANOTIC HEART DISEASE; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; FIBRINOLYSIS; HEMODILUTION; HUMAN; LABORATORY TEST; LIVER DISEASE; PATHOPHYSIOLOGY; PHLEBOTOMY; POLYCYTHEMIA; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; STERNOTOMY; THROMBOCYTE ANOMALY; THROMBOCYTOPENIA; ULTRAFILTRATION; VITAMIN K DEFICIENCY;

EID: 0036945831     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/jcan.2002.128436     Document Type: Review

References (120)

1. Colon-Otero G, Gilchrist GS, Holcomb GR, et al: Preoperative evaluation of hemostasis in patients with congenital heart disease. Mayo Clin Proc 62:379-385, 1987
2. Maurer HM, McCue CM, Robertson LW, Haggins JC: Correction of platelet dysfunction and bleeding in cyanotic congenital heart disease by simple red cell volume reduction. Am J Cardiol 35:831-835, 1975
3. Henriksson P, Varendh G, Lundstrom NR: Haemostatic defects in cyanotic congenital heart disease. Br Heart J 41:23-27, 1979
4. Gross S, Keefer V, Liebman J: The platelets in cyanotic congenital heart disease. Pediatrics 42:651-658, 1968
5. Waldman JD, Czapek EE, Paul MH, et al: Shortened platelet survival in cyanotic heart disease. J Pediatr 87:77-79, 1975
6. Goldschmidt B: Effect of vitamin K on clotting factors in children with congenital cyanotic heart disease. Acta Paediatr Acad Sci Hung 11:135-139, 1970
7. Brodsky I, Gill DN, Lusch CJ: Fibrinolysis in congenital heart disease: Preoperative treatment with E-aminocaproic acid. Am J Clin Pathol 51:51-57, 1969
8. Dennis LH, Stewart JL, Conrad ME: Heparin treatment of haemorrhagic diathesis in cyanotic congenital heart disease. Lancet 1:1088-1089, 1967
9. Ihenacho HN, Breeze GR, Fletcher DJ,. Stuart J: Consumption coagulopathy in congenital heart disease. Lancet 1:231-234, 1973
10. Komp DM, Sparrow AW: Polycythemia in cyanotic heart disease: A study of altered coagulation. J Pediatr 76:231-236, 1970
11. Guay J, Rivard GE: Mediastinal bleeding after cardiopulmonary bypass in pediatric patients. Ann Thorac Surg 62:1955-1960, 1996
12. Dore A, Glancy DL, Stone S, et al: Cardiac surgery for grown-up congenital heart patients: Survey of 307 consecutive operations from 1991 to 1994. Am J Cardiol 80:906-913, 1997
13. Bahnson HT, Ziegler RF: A consideration of the causes of death following operation for congenital heart disease of the cyanotic type. Surg Gynecol Obstet 90:60, 1950
14. Hartmann RC: A haemorrhagic disorder occurring in patients with cyanotic congenital heart disease. Bull Johns Hopkins Hosp 91:49, 1955
15. Wedemeyer AL, Edson JR, Krivit W: Coagulation in cyanotic congenital heart disease. Am J Dis Child 124:656-660, 1972
16. Gidding SS, Bessel M, Liao YL: Determinants of hemoglobin concentration in cyanotic heart disease. Pediatr Cardiol 11:121-125, 1990
17. Perloff JK, Rosove MH, Sietsema KE, Territo MC: Cyanotic congenital heart disease: A multisystem disorder. In Perloff JK, Child JS (eds): Congenital Heart Diseases in Adults (Ed 2). Philadelphia, PA, WB Saunders, 1998, pp 199-226
18. Golde DW, Hocking WG, Koeffler HP, Adamson JW: Polycythemia: Mechanisms and management. Ann Intern Med 95:71-87, 1981
19. Gidding SS, Stockman JA III, Goldwassser E: Erythropoietin in cyanotic heart disease. Am Heart J 116:128-132, 1988
20. Tyndall MR, Teitel DF, Lutin WA, et al: Serum erythropoietin levels in patients with congenital heart disease. J Pediatr 110:538-544, 1987
21. Linderkamp O, Klose HJ, Betke K, et al: Increased blood viscosity in patients with cyanotic congenital heart disease and iron deficiency. J Pediatr 95:567-569, 1979
22. Schmid-Schonbein H, Wells R, Goldstone J: Influence of deformability of human red cells upon blood viscosity. Circ Res 25:131-143, 1969
23. Grotta JC, Manner C, Pettigrew LC, Yatsu FM: Red blood cell disorders and stroke. Stroke 17:811-817, 1986
24. Giddings SS, Stockman JA: Effect of iron deficiency on tissue oxygen delivery in cyanotic congenital heart disease. Am J Cardiol 61:605-607, 1988
25. Hutton RD: The effect of iron deficiency on whole blood viscosity in polycythaemic patients. Br J Haematol 43:191-199, 1979
26. Wells R: Syndromes of hyperviscosity. N Engl J Med 283:183-186, 1970
27. Gaiha M, Sethi HP, Sudha R, et al: A clinicohematological study with hyperviscosity symptoms in cyanotic congenital heart disease. Ind Heart J 45:53-55, 1993
28. Dallman PR, Siimes MA, Stekel A: Iron deficiency in infancy and childhood. Am J Clin Nutr 33:86-118, 1980
29. Naiman JL: Clotting and bleeding in cyanotic congenital heart disease. J Pediatr 76:333-335, 1970
30. Ekert H, Gilchrist GS: Coagulation studies in congenital heart disease. Lancet Aug 3; 2(7562) 280, 1968 (letter)
31. Maurer HM, McCue CM, Caul J, Still WJS: Impairment in platelet aggregation in congenital heart disease. Blood 40:207-216, 1972
32. Bhargava M, Sanyal SK, Thapar MK, et al: Impairment of platelet adhesiveness and platelet factor 3 activity in cyanotic congenital heart disease. Acta Hematol 55:216-223, 1976
33. Ekert H, Sheers M: Preoperative and postoperative platelet function in cyanotic congenital heart disease. J Thorac Cardiovasc Surg 67:184-190, 1974
34. Ekert H, Dowling SV: Platelet release abnormality and reduced prothrombin levels in children with cyanotic congenital heart disease. Aust Paediatr J 13:17-21, 1977
35. Goldschmidt B, Sarkadi B, Gardos G, Matlary A: Platelet production and survival in cyanotic congenital heart disease. Scand J Haematol 13:110-115, 1974
36. Verel D: Blood volume changes in cyanotic congenital heart disease and polycythemia rubra vera. Circulation 23:749-753, 1961
37. Replogle RL, Meiselman HJ, Merrill EW: Clinical implications of blood rheology studies. Circulation 36:148-160, 1967
38. Dennis LH, Stewart JL, Conrad ME: A consumption coagulation defect in congenital cyanotic heart disease and its treatment with heparin. J Pediatr 71:407-410, 1967
39. Patil AS, Sarup BM, Mehta S: Consumption coagulopathy in a child with congenital cyanotic heart disease and its treatment with heparin. Ind J Pediatr 42:17-21, 1975
40. Johnson CA, Abildgaard CF, Schulman I: Absence of coagulation abnormalities in children with cyanotic congenital heart disease. Lancet 2:660-662, 1968
41. Gralnick HR: ε-Aminocaproic acid in preoperative correction of hemostatic defect in cyanotic congenital heart disease. Lancet 1:1204-1205, 1970
42. McLoughlin TM Jr, Greilich PE: Preexisting hemostatic defects and bleeding disorders. In Lake CL, Moore RA (eds): Blood: Hemostasis, Transfusion and Alternatives in the Perioperative Period. New York, NY: Raven Press, 1995, pp 25-70
43. Kern FH, Morana NJ, Sears JJ, Hickey PR: Coagulation defects in neonates during cardiopulmonary bypass. Ann Thorac Surg 54:541-546, 1992
44. Goel M, Shome DK, Singh ZN, et al: Haemostatic changes in children with cyanotic and acyanotic congenital heart disease. Ind Heart J 52-559-563, 2000
45. Levin E, Wu J, Devine DV, et al: Hemostatic parameters and platelet activation marker expression in cyanotic and acyanotic pediatric patients undergoing cardiac surgery in the presence of tranexamic acid. Thromb Haemost 83:54-59, 2000
46. von Kaulla KN, Paton BC, Rosenkrantz JG, et al: Preoperative correction of coagulation in tetralogy of Fallot. Arch Surg 94:107-111, 1967
47. Manno CS, Hedberg KW, Kim HC, et al: Comparison of the hemostatic effects of fresh whole blood, stored whole blood, and components after open heart surgery in children. Blood 77:930-936, 1991
48. Chauhan S, Kumar BA, Rao BH, et al: Efficacy of aprotinin, epsilon-aminocaproic acid, or combination in cyanotic heart disease. Ann Thorac Surg 70:1308-1312, 2000
49. DeLeon SY, LoCicero III J, Ilbawi MN, Idriss FS: Repeat median sternotomy in pediatrics: Experience in 164 consecutive cases. Ann Thorac Surg 41:184-188, 1986
50. Gomes MM, McGoon DC: Bleeding patterns after open heart surgery. J Thorac Cardiovasc Surg 60:87-97, 1970
51. Andrew M, Paes B, Milner R, et al: Development of the human coagulation system in the full-term infant. Blood 70:165-172, 1987
52. Greeley WJ, de Bruijn NP: Changes in sufentanil pharmacokinetics within the neonatal period. Anesth Analg 67:86-90, 1988
53. Morselli PL, Franco-Morselli R, Bossi L: Clinical pharmacokinetics in newborns and infants: Age-related differences and therapeutic implications. Clin Pharmacokinet 5:485-527, 1980
54. Dietrich W, Mossinger H, Spannagl M, et al: Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations. J Thorac Cardiovasc Surg 105:712-720, 1993
55. Zonis Z, Seear M, Reichert C, et al: The effect of preoperative tranexamic acid on blood loss after cardiac operation in children. J Thorac Cardiovasc Surg 111:982-987, 1996
56. Suarez CR, Menendez CE, Griffin AJ, et al: Cyanotic congenital heart disease in children: Hemostatic disorders and relevance of molecular markers of hemostasis. Semin Thromb Hemost 10:285-289, 1984
57. Jackson DP: Hemorrhagic diathesis in patients with cyanotic congenital heart disease: Preoperative management. Ann N Y Acad Sci 115:235-251, 1964
58. Territo MC, Rosove MH: Cyanotic congenital heart disease: Hematologic management. J Am Coll Cardiol 18:320-322, 1991
59. Paridon SM: Consequences of chronic hypoxemia and pulmonary vascular disease. In Garson A, Bricker JT, Fisher DJ, Neish SR (eds): The Science and Practice of Pediatric Cardiology (Ed 2). Philadelphia, PA, Williams & Wilkins, 1998, pp 2261-2272
60. Phornphutkul C, Rosenthal A, Nadas AS, Berenberg W: Cerebrovascular accidents in infants and children with cyanotic congenital heart disease. Am J Cardiol 32:329-334, 1973
61. Thomas DJ, du Boulay GH, Marshall J, et al: Cerebral blood flow in polycythemia. Lancet 2:161-163, 1977
62. Ammash N, Warnes CA: Cerebrovascular events in adult patients with cyanotic congenital heart disease. J Am Coll Cardiol 28: 768-772, 1996
63. Cottrill CM, Kaplan S: Cerebral vascular accidents in cyanotic congenital heart disease. Am J Dis Child 125:484-487, 1973
64. Perloff JK: Systemic complications of cyanosis in adults with congenital heart disease: Hematologic derangements, renal function, and urate metabolism. Cardiol Clin 11:689-699, 1993
65. Rosove MH, Perloff JK, Hocking WG, et al: Chronic hypoxaemia and decompensated erythrocytosis in cyanotic congenital heart disease. Lancet 2:313-315, 1986
66. Swan L, Birnie DH, Hillins WS: The hematological management of patients with cyanotic congenital heart disease: A time for consensus. Eur Heart J 18:1973-1976, 1997
67. Rosenthal A, Nathan DG, Marty AT, et al: Acute hemodynamic effects of red cell volume reduction in polycythemia of cyanotic congenital heart disease. Circulation 42:297-308, 1970
68. Berman W Jr, Berman N, Pathak D, Wood SC: Effects of pentoxifylline (Trental) on blood flow, viscosity, and oxygen transport in young adults with inoperable cyanotic congenital heart disease. Pediatr Cardiol 15:66-70, 1994
69. Stammers AH, Rauch ED, Willett LD, et al: Preoperative coagulopathy management of a neonate with complex congenital heart disease: A case study. Perfusion 15:161-168, 2000
70. Herynkopf F, Lucchese F, Pereira E, et al: Aprotinin in children undergoing correction of congenital heart defects. J Thorac Cardiovasc Surg 108:517-521, 1994
71. Penkoske PA, Entwistle LM, Marchak BE, et al: Aprotinin in children undergoing repair of congenital heart defects. Ann Thorac Surg 60:S529-S532, 1995
72. Elliott MJ, Allen A: Aprotinin in pediatric cardiac surgery. Perfusion 5:73-76, 1990 (suppl)
73. Urban AE, Popov-Cenic S, Noe G, Kulzer R: Aprotinin in open heart surgery of infants and children using the heart-lung machine. Clin Ther 6:325-333, 1984
74. Hazan E, Pasaoglu I, Demircin M, Bozer AY: The effect of aprotinin (Trasylol) on postoperative bleeding in cyanotic congenital heart disease. Turk J Pediatr 33:109-110, 1991
75. Boldt J, Knothe C, Zickmann B, et al: Comparison of two aprotinin dosage regimens in pediatric patients having cardiac operations: Influence on platelet function and blood loss. J Thorac Cardiovasc Surg 105:705-711, 1993
76. Boldt J, Zickmann B, Schindler E, et al: Influence of aprotinin on the thrombomodulin/protein C system in pediatric cardiac operations. J Thorac Cardiovasc Surg 107:1215-1221, 1994
77. Ranucci M, Corno A, Pavesi M, et al: Renal effects of low-dose aprotinin in pediatric cardiac surgery. Min Anestesiol 60:361-366, 1994
78. Miller BE, Tosone SR, Tam VKH, et al: Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. Ann Thorac Surg 66:535-541, 1998
79. D'Errico CC, Shayevitz JR, Martindale SJ, et al: The efficacy and cost of aprotinin in children undergoing reoperative open heart surgery. Anesth Analg 83:1193-1199, 1996
80. Ohuchi H, Okabe H, Nagata N, Kaneko Y: Aprotinin reduces homologous blood transfusions when pediatric cardiac surgery must be redone. Nippon Kyobu Geka Gakkai Zasshi 44:1980-1985, 1996
81. Carrel TP, Schwanda M, Vogt PR, Turina MI: Aprotinin in pediatric cardiac operations: A benefit in complex malformations and with high-dose regimen only. Ann Thorac Surg 66:153-158, 1998
82. Davies MJ, Allen A, Kort H, et al: Prospective, randomized, double-blind study of high-dose aprotinin in pediatric cardiac operations. Ann Thorac Surg 63:497-503, 1997
83. van Oeveren W, Harder MP, Roozendaal KJ, et al: Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. J Thorac Cardiovasc Surg 99:788-796, 1990
84. Marx G, Pokar H, Reuter H, et al: The effects of aprotinin on hemostatic function during cardiac surgery. J Cardiothorac Vasc Anesth 5:467-474, 1991
85. Royston D, Bidstrup BP, Taylor KM, Sapsford RN: Effect of aprotinin on need for blood transfusion after repeat open heart surgery. Lancet 2:1289-1291, 1987
86. Dietrich W, Spannagl M, Jochum M: Influence of high-dose aprotinin treatment on blood loss and coagulation patterns in patients undergoing myocardial revascularization. Anesthesiology 73:1119-1126, 1990
87. Mossinger H, Dietrich W: Activation of hemostasis during cardiopulmonary bypass and pediatric aprotinin dosage. Ann Thorac Surg 65:S45-S51, 1998
88. D'Errico CC, Munro HM, Bove EL: Pro: The routine use of aprotinin during pediatric cardiac surgery is a benefit. J Cardiothorac Vasc Anesth 13:782-784, 1999
89. Mojcik CF, Levy JH: Aprotinin and the systemic inflammatory response after cardiopulmonary bypass. Ann Thorac Surg 71:745-754, 2001
90. Youngberg JA: Aprotinin and thrombus formation on pulmonary artery catheters: A piece of the coagulation puzzle. J Cardiothorac Vasc Anesth 4:155-158, 1990
91. Bohrer H, Bach A, Fleischer F, Lang J: Adverse hemodynamic effects of high-dose aprotinin in a paediatric cardiac surgical patient. Anaesthesia 45:853-854, 1990
92. Dietrich W, Spath P, Zuhlsdorf M, et al: Anaphylactic reactions to aprotinin reexposure in cardiac surgery. Anesthesiology 95:64-71, 2001
93. Williams GD, Ramamoorthy C: Con: The routine use of aprotinin during pediatric cardiac surgery is not a benefit. J Cardiothorac Vasc Anesth 13:785-788, 1999
94. Edmunds LH: Aprotinin use in pediatric cardiac operations. J Thorac Cardiovasc Surg 105:757, 1993 (letter)
95. Slaughter TF, Faghih F, Greenberg CS, et al: The effects of epsilon-aminocaproic acid on fibrinolysis and thrombin generation during cardiac surgery. Anesth Analg 85:1221-1226, 1997
96. McClure PD, Izasak J: The use of epsilon-aminocaproic acid to reduce bleeding during cardiac bypass in children with congenital heart disease. Anesthesiology 40:604-608, 1974
97. Rao BH, Saxena N, Chauhan S, et al: Epsilon-aminocaproic acid in paediatric cardiac surgery to reduce postoperative blood loss. Ind J Med Res 3:57-61. 2000
98. Williams GD, Bratton SL, Riley EC, Ramamoorthy C: Efficacy of ε-aminocaproic acid in children undergoing cardiac surgery. J Cardiothorac Vasc Anesth 13:304-308, 1999
99. Bennett-Guerrero E, Sorohan JG, Canada AT, et al: Epsilon-aminocaproic acid plasma levels during cardiopulmonary bypass. Anesth Analg 85:248-251, 1997
100. Ririe DG, James RL, O'Brien JJ, et al: The pharmacokinetics of ε-aminocaproic acid in children undergoing surgical repair of congenital heart defects. Anesth Analg 94:44-49, 2002
101. Kennedy DJ, Gravlee GP: Pharmacologic manipulation of coagulation: Promotion of hemostasis. In Lake CL, Moore RA (eds): Blood: Hemostasis, Transfusion and Alternatives in the Perioperative Period. New York, NY, Raven Press, 1995, pp 131-149
102. Soslau G, Horrow J, Brodsky I: Effect of tranexamic acid on platelet ADP during extracorporeal circulation. Am J Hematol 38:113-119, 1991
103. Reid RW, Zimmerman AA, Lausen PC, et al: The efficacy of tranexamic acid versus placebo in decreasing blood loss in pediatric patients undergoing repeat cardiac surgery. Anesth Analg 84:990-996, 1997
104. Horrow J: Transfusion medicine and coagulation disorders. In Kaplan JA (ed): Cardiac Anesthesia (Ed 4). Philadelphia, PA, Saunders, 1999, pp 1111-1154
105. Mannucci PM, Remuzzi G, Pusineri F, et al: Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med 308:8, 1983
106. Salzman EW, Weinstein M, Weintraub R, et al: Treatment with desmopressin acetate to reduce blood loss after cardiac surgery: A double-blind randomized trial. N Engl J Med 314:1402-1406, 1986
107. Seear MD, Wadsworth LD, Rogers PC, et al: The effect of desmopressin acetate (DDAVP) on postoperative blood loss after cardiac operations in children. J Thorac Cardiovasc Surg 98:217-219, 1989
108. Reynolds LM, Nicolson SC, Jobes DR, et al: Desmopressin does not decrease bleeding after cardiac operation in young children. J Thorac Cardiovasc Surg 106:954-958, 1993
109. Mohr R, Martionowitz U, Lavee, J, et al: The hemostatic effect of transfusing fresh whole blood versus platelet concentrates after cardiac operations. J Thorac Cardiovasc Surg 96:530-534, 1988
110. Golan M, Modan M, Lavee J, et al: Transfusion of fresh whole blood stored (4°C) for short period fails to improve platelet aggregation on extracellular matrix and clinical hemostasis after cardiopulmonary bypass. J Thorac Cardiovasc Surg 99:354-360, 1990
111. Perloff JK, Child JS (eds): Congenital Heart Diseases in Adults (Ed 2). Philadelphia, PA, Saunders, 1998, p 210
112. Takahashi Y, Tatsuno K, Kikuchi T: Open heart surgery with bloodless priming for cyanotic congenital heart diseases: The role of autologous blood donation after induction of anaesthesia. Nippon Kyobu Geka Gakkai Zasshi 44:1075-1081, 1996
113. Takahashi Y, Tatsuno K, Kikuchi T, et al: Open heart surgery without blood transfusion for complete atrioventricular septal defect associated with tetralogy of Fallot. Nippon Kyobu Geka Gakkai Zasshi 45:170-173, 1997
114. Friesen RH, Tornabene MA, Coleman SP: Blood conservation during pediatric cardiac surgery: Ultrafiltration of the extracorporeal circuit volume after cardiopulmonary bypass. Anesth Analg 77:702-707, 1993
115. Gaynor JW: Use of modified ultrafiltration after repair of congenital heart defects. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 1:81-90, 1998
116. Journois D, Israel-Biet D, Pouard P, et al: High-volume, zero-balanced hemofiltration to reduce delayed inflammatory response to cardiopulmonary bypass in children. Anesthesiology 85:952-960, 1996
117. Milam JD, Austin SF, Nihill MR, et al: Use of sufficient hemodilution to prevent coagulopathies following surgical correction of cyanotic heart disease. J Thorac Cardiovasc Surg 89:623-629, 1985
118. Kawaguchi A, Bergsland J, Subramanian S: Total bloodless open heart surgery in the pediatric age group. Circulation 70:130-137, 1984
119. Stein JI, Gombotz H, Rigler B, et al: Open heart surgery in children of Jehovah's witnesses: Extreme hemodilution on cardiopulmonary bypass. Pediatr Cardiol 12:170-174, 1991
120. Lake CL: Postoperative complications. In Lake CL (ed): Pediatric Cardiac Anesthesia (Ed 2). Norwalk, CT, Appleton & Lange, 1993, pp 465-483